ePRO / eCOA

Sponsor and CRO’s Choice: Holistic On-Site, At-Home, and Virtual eSource Flexibility for Clinical Trials

Sometimes, it seems like your trial needs to tiptoe around what your technology can and can’t do. It doesn’t have to be that way.

Read More
Jonathan Andrus Jonathan Andrus December 18, 2020
ePRO / eCOA

Mixed-Modality Deployment Compatible With Any Trial Design

Part I (of III)

Read More
Doug Pierce Doug Pierce December 2, 2020

Receive Industry Updates
SUBSCRIBE TO OUR BLOG

Filter By Category

See all

Filter By Author

See all

More Articles

ePRO / eCOA

A Unified Experience in eSource Patient Data Capture and Integration for Sites and Sponsors

ePRO / eCOA

One Patient Data Capture Application That’s Everything to Everyone: The Evolution of Lunexis™ ePRO+

ePRO / eCOA / CNS

Making Data Central to Your CNS and Pain Trials: A Therapeutic-Area-Specific Approach to Data Capture Solutions

eSource DDC

DDC vs. EDC: Frequently Asked Questions

Gastrointestinal / ePRO / eCOA

Handling Complexity in GI Trials ⁠— a Purpose-Built eCOA/ePRO Solution: The GI Library

Lupus / eCOA

Lupus Studies Deserve a Better Approach

All posts

About Clinical Ink

Clinical Ink, a global clinical technology company, offers data certainty from source to submission via our Lunexis™ eSource clinical technology and configurable direct data capture (DDC), eCOA, ePRO, and eConsent modules. This suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source naturally enhances clinical trial workflows. For decentralized or traditional trials, Lunexis technology reduces manual labor and provides anytime, anywhere data access, saving resources as your trials progress. For more information, visit clinicalink.com.